Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN103102231B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103102231B reveals a one-step chiral Lewis acid catalyzed route for high-purity 4-hydroxypiperidine intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.